• English
    • français
  • Aide
  •  | 
  • Contact
  •  | 
  • À Propos
  •  | 
  • Ouvrir une session
  • Portail HAL
  •  | 
  • Pages Pro Chercheurs
  • EN
  •  / 
  • FR
Voir le document 
  •   Accueil de LillOA
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • Voir le document
  •   Accueil de LillOA
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • Voir le document
JavaScript is disabled for your browser. Some features of this site may not work without it.

Ovarian hyperstimulation syndrome after ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Type de document :
Article dans une revue scientifique: Article original
DOI :
10.1016/j.gofs.2017.03.004
PMID :
28461237
URL permanente :
http://hdl.handle.net/20.500.12210/17222
Titre :
Ovarian hyperstimulation syndrome after stimulation with highly purified hmgfor in vitro fertilization: observational study shoview
Auteur(s) :
Barriere, P. [Auteur]
Dewailly, Didier [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer (JPArc) - U1172

Duhamel, Alain [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Gayet, V. [Auteur]
Titre de la revue :
Gynecologie, obstetrique, fertilite & senologie
Nom court de la revue :
Gynecol. Obstet. Fertil. Senol.
Numéro :
45
Pagination :
283-290
Date de publication :
2017-05-01
ISSN :
2468-7197
Mot(s)-clé(s) en anglais :
Controlled ovarian hyperstimulation
HP-hMG
Ovarian hyperstimulation syndrome
In vitro fertilization
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
OBJECTIVE: Data on the incidence and severity of ovarian hyperstimulation syndrome (OHSS) in France are limited. METHODS: Prospective observational multicentric study (23 French centers of IVF) in a cohort of 421 women ...
Lire la suite >
OBJECTIVE: Data on the incidence and severity of ovarian hyperstimulation syndrome (OHSS) in France are limited. METHODS: Prospective observational multicentric study (23 French centers of IVF) in a cohort of 421 women treated with highly purified hMG (HP-hMG) for the first or second cycle of IVF with or without ICSI. The primary objective was to assess the incidence of moderate to severe OHSS in this cohort. RESULTS: At inclusion, 172 patients (40.9%) were considered at risk of OHSS by the physicians. The main measures for risk minimization taken by the physicians rested on initial dose of HP-hMG and protocol choice. At the end of the follow-up (4 months in average), the rate of OHSS moderate to severe was 2.4% (confidence interval 95%: 1.1-4.3%) for the studied IVF cycle. OHSS was severe for 3 women (0.7%) and moderate for 7 women (1.7%). CONCLUSIONS: This rate of OHSS after IVF is at the lower limit of the rates reported in the literature for OHSS. This study brings reassuring epidemiological data on the rate of OHSS in women at risk. The measures taken by the physicians to minimize the risk of OHSS could have contributed to this low incidence.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Inserm
Université de Lille
Collections :
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Date de dépôt :
2019-12-09T18:16:55Z
Université de Lille

Mentions légales
Accessibilité : non conforme
Université de Lille © 2017